Extensively Drug-Resistant Tuberculosis: Report and Literature Review on Two Cases Requiring Prolonged Treatment.
BACKGROUND Extensively drug-resistant tuberculosis (XDR-TB) is a global problem due to the high morbidity and mortality it causes. Peru is one of the countries with the highest numbers of cases of XDR-TB, which increase every year. CASE REPORT We present the case of two siblings who developed XDR-TB, underwent surgery twice, and were in individualized treatment for more than 6 years. Finally they achieved remission of symptoms, despite not having standardized treatment schemes during their diagnosis period. CONCLUSIONS Extensively drug-resistant tuberculosis can be cured with a treatment that involves both medical care and patient actions to achieve remission of the disease.
, Medical College of Peru, Lima, Peru.
Martha
M
Matos-Tocasca
, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Gabriel
G
De la Cruz-Ku
, Medical Student at Universidad Científica del Sur (UCSUR), LimaLima-Perú, Peru.
Erick
E
Auccacusi
, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Diego
D
Fernandez-Salas
, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Tatiana
T
García-Ahuanari
, Medical Student at Universidad Científica del Sur (UCSUR), Lima, Peru.
Bryan
B
Valcarcel-Valdivia
D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D054908:Extensively Drug-Resistant Tuberculosis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification*; D013997:Time Factors; D014374:Tuberculin Test; D055815:Young Adult
D000995:Antitubercular Agents